Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Madrigal Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
MDGL
Nasdaq
2834
https://www.madrigalpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Apr 16th, 2024 8:05 pm
Latest Insider Selling in April 2024: 10 Stocks to Watch
- Apr 15th, 2024 8:28 pm
Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
- Apr 9th, 2024 12:00 pm
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
- Apr 5th, 2024 11:15 am
Madrigal Pharmaceuticals Inc Director James Daly Sells 32,489 Shares
- Apr 4th, 2024 5:55 am
Madrigal Pharmaceuticals Inc Director Richard Levy Sells 11,000 Shares
- Apr 4th, 2024 5:54 am
Madrigal Pharmaceuticals Inc Director Kenneth Bate Sells 32,489 Shares
- Apr 4th, 2024 5:54 am
1 No-Brainer Growth Stock to Buy Now
- Apr 3rd, 2024 12:45 pm
The 3 Best Biotech Stocks to Buy in April 2024
- Apr 2nd, 2024 1:09 am
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
- Mar 29th, 2024 1:00 pm
Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?
- Mar 29th, 2024 8:43 am
Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock
- Mar 26th, 2024 1:53 pm
This Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy?
- Mar 22nd, 2024 10:15 am
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
- Mar 19th, 2024 9:50 am
Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering
- Mar 19th, 2024 3:58 am
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
- Mar 19th, 2024 12:01 am
Madrigal Pharmaceuticals Announces Proposed Public Offering
- Mar 18th, 2024 8:04 pm
Madrigal Pharmaceuticals Stock Hits 80-Plus Relative Strength Rating Benchmark
- Mar 18th, 2024 7:15 pm
Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That
- Mar 18th, 2024 11:00 am
30 Biggest Biotechnology Companies in the World
- Mar 17th, 2024 12:50 pm
Scroll